Kulkarni Samarth

CIK 00016820195 companiesBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001682019

Recent Transactions

50 trades

Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2026-01-22$60.23/sh−60,000→ 134,201 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2026-01-20$52.10/sh−8,567→ 194,201 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2026-01-20$51.61/sh−21,433→ 202,768 total
Gift
CRISPR Therapeutics AG$CRSP
Common Shares
2025-12-18−30,000→ 224,201 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2025-10-17$67.91/sh−50,895→ 254,201 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2025-10-16+100,000→ 305,096 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2025-10-16−100,000→ 300,000 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2025-10-14$66.60/sh−4,242→ 205,096 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2025-10-13+8,334→ 209,338 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2025-10-13−8,334→ 8,333 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2025-10-03+49,500→ 49,500 total
Gift
CRISPR Therapeutics AG$CRSP
Common Shares
2025-09-17−6,000→ 201,004 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2025-08-18$58.15/sh−13,081→ 207,004 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2025-08-16−25,000→ 0 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2025-08-16+25,000→ 220,085 total
Award
Centessa Pharmaceuticals plc$CNTA
Share Option (right to buy)
2025-06-20+40,000→ 40,000 total
Award
Black Diamond Therapeutics, Inc.$BDTX
Stock Option (Right to Buy)
2025-06-12+30,550→ 30,550 total
Award
Oruka Therapeutics, Inc.$ORKA
Stock Option (right to buy)
2025-06-02+17,500→ 17,500 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2025-03-21$41.23/sh−10,031→ 195,085 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2025-03-20−19,688→ 59,062 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2025-03-20+19,688→ 205,116 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2025-03-14+110,000→ 110,000 total
Award
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2025-03-14+82,500→ 82,500 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2025-03-12$43.32/sh−4,462→ 185,428 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2025-03-11−9,000→ 0 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2025-03-11+9,000→ 189,890 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2025-03-11$42.42/sh−9,973→ 180,890 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2025-03-10+19,250→ 190,863 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2025-03-10−19,250→ 38,500 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2025-02-19$55.20/sh−18,360→ 171,613 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2025-02-19$52.80/sh−6,928→ 189,973 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2025-02-18$55.05/sh−11,640→ 196,901 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2025-02-18−13,250→ 13,250 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2025-02-18+13,250→ 208,541 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2024-12-24$16.21/sh+13,751→ 195,291 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2024-12-24−13,751→ 0 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2024-12-02$55.10/sh−15,000→ 181,540 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2024-11-11$55.43/sh−23,121→ 203,419 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2024-11-11$56.27/sh−6,879→ 196,540 total
Award
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2024-10-16+400,000→ 400,000 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2024-10-16+55,000→ 55,000 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2024-10-14$46.28/sh−4,293→ 226,540 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2024-10-13−8,333→ 16,667 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2024-10-13+8,333→ 230,833 total
Gift
CRISPR Therapeutics AG$CRSP
Common Shares
2024-08-08−100,000→ 222,500 total
Award
Centessa Pharmaceuticals plc$CNTA
Share Option (right to buy)
2024-06-25+48,000→ 48,000 total
Award
Repare Therapeutics Inc.$RPTX
Stock Option (right to buy)
2024-06-17+27,200→ 27,200 total
Award
Black Diamond Therapeutics, Inc.$BDTX
Stock Option (Right to Buy)
2024-06-06+30,550→ 30,550 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2024-04-15−19,582→ 0 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2024-04-15$59.88/sh−18,378→ 209,326 total

Companies

Recent Filings

Address

C/O CRISPR THERAPEUTICS 105 WEST FIRST STREET

BOSTON, MA, 02127

View on SEC.gov